Chengdu Kanghua (China) Performance
300841 Stock | 60.97 0.22 0.36% |
Chengdu Kanghua has a performance score of 4 on a scale of 0 to 100. The firm shows a Beta (market volatility) of -0.67, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Chengdu Kanghua are expected to decrease at a much lower rate. During the bear market, Chengdu Kanghua is likely to outperform the market. Chengdu Kanghua Biol right now shows a risk of 2.05%. Please confirm Chengdu Kanghua Biol semi deviation, coefficient of variation, and the relationship between the mean deviation and downside deviation , to decide if Chengdu Kanghua Biol will be following its price patterns.
Risk-Adjusted Performance
Insignificant
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Chengdu Kanghua Biological are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Chengdu Kanghua may actually be approaching a critical reversion point that can send shares even higher in April 2025. ...more
Begin Period Cash Flow | 636 M |
Chengdu |
Chengdu Kanghua Relative Risk vs. Return Landscape
If you would invest 5,729 in Chengdu Kanghua Biological on December 19, 2024 and sell it today you would earn a total of 368.00 from holding Chengdu Kanghua Biological or generate 6.42% return on investment over 90 days. Chengdu Kanghua Biological is generating 0.1279% of daily returns and assumes 2.0502% volatility on return distribution over the 90 days horizon. Simply put, 18% of stocks are less volatile than Chengdu, and 98% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
Risk |
Chengdu Kanghua Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Chengdu Kanghua's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Chengdu Kanghua Biological, and traders can use it to determine the average amount a Chengdu Kanghua's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0624
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | 300841 | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
2.05 actual daily | 18 82% of assets are more volatile |
Expected Return
0.13 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average Chengdu Kanghua is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Chengdu Kanghua by adding it to a well-diversified portfolio.
Chengdu Kanghua Fundamentals Growth
Chengdu Stock prices reflect investors' perceptions of the future prospects and financial health of Chengdu Kanghua, and Chengdu Kanghua fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Chengdu Stock performance.
Return On Equity | 0.16 | ||||
Return On Asset | 0.11 | ||||
Profit Margin | 0.33 % | ||||
Operating Margin | 0.36 % | ||||
Current Valuation | 7.6 B | ||||
Shares Outstanding | 132.95 M | ||||
Price To Book | 2.36 X | ||||
Price To Sales | 4.91 X | ||||
Revenue | 1.58 B | ||||
EBITDA | 735.65 M | ||||
Total Debt | 190.91 M | ||||
Book Value Per Share | 26.59 X | ||||
Cash Flow From Operations | 573.98 M | ||||
Earnings Per Share | 4.12 X | ||||
Total Asset | 4.21 B | ||||
Retained Earnings | 2.26 B | ||||
About Chengdu Kanghua Performance
By analyzing Chengdu Kanghua's fundamental ratios, stakeholders can gain valuable insights into Chengdu Kanghua's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Chengdu Kanghua has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Chengdu Kanghua has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Things to note about Chengdu Kanghua Biol performance evaluation
Checking the ongoing alerts about Chengdu Kanghua for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Chengdu Kanghua Biol help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.About 36.0% of the company shares are owned by insiders or employees |
- Analyzing Chengdu Kanghua's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Chengdu Kanghua's stock is overvalued or undervalued compared to its peers.
- Examining Chengdu Kanghua's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Chengdu Kanghua's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Chengdu Kanghua's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Chengdu Kanghua's stock. These opinions can provide insight into Chengdu Kanghua's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Chengdu Stock analysis
When running Chengdu Kanghua's price analysis, check to measure Chengdu Kanghua's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chengdu Kanghua is operating at the current time. Most of Chengdu Kanghua's value examination focuses on studying past and present price action to predict the probability of Chengdu Kanghua's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chengdu Kanghua's price. Additionally, you may evaluate how the addition of Chengdu Kanghua to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |